Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
(25 sites) China
Anhui Provincial Cancer Hospital, Hefei, Anhui Anhui Provincial Hospital, Hefei, Anhui Beijing Tiantan Hospital,Capital Medical University, Beijing, Beijing Municipality Gansu Provincial Cancer Hospital, Lanzhou, Gansu Gansu Provincial Cancer Hospital, Lanzhou, Gansu Shantou Central Hospital, Shantou, Guangdong Affiliated Cancer Hospital of Harbin Medical University, Harbin, Heilongjiang Huaihe Hospital of Henan University, Kaifeng, Henan Puyang Oilfield General Hospital, Puyang, Henan The Third People's Hospital of Zhengzhou, Zhengzhou, Henan Zhongnan Hospital of Wuhan University, Wuhan, Hubei Hunan Cancer Hospital, Changsha, Hunan Jiangsu Provincial People's Hospital, Nanjing, Jiangsu The first hospital of Jilin University, Changchun, Jilin Affiliated Zhongshan Hospital Of Dalian University, Dalian, Liaoning Affiliated Zhongshan Hospital Of Dalian University, Dalian, Liaoning Liaoning Provincial Cancer Hospital, Shenyang, Liaoning The First Affiliated Hospital of Xi'An Jiaoting Yniversity, Xi'an, Shaanxi Cancer Hospital of Shandong First Medical University, Jinan, Shandong Fudan University shanghai cancer center, Shanghai, Shanghai Municipality Shanxi Cancer Hospital, Taiyuan, Shanxi Yuncheng Central Hospital, Shanxi Province, Yuncheng, Shanxi Tianjin Cancer Hospital Airport Hospital, Tianjin, Tianjin Municipality Tianjin Medical University Cancer Institute & Hospital, Tianjin, Tianjin Municipality The Affiliated Tumor Hospital of Xinjiang Medical University, Ürümqi, Xinjiang